After being informed about the study, all patients meeting the inclusion/exclusion criteria and giving written informed consent will receive a nutraceutical containing L. rhamnosus, L. plantarum and L. crispatus once daily.
The aim of this study is to determine the efficacy of an oral nutraceutical with probiotics in restore vaginal health.